Goldman Sachs’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.28M | Sell |
|
|||||
|
2025
Q1 | $7.18M | Buy |
|
|||||
|
2024
Q4 | $6.6M | Sell |
|
|||||
|
2024
Q3 | $10.8M | Buy |
|
|||||
|
2024
Q2 | $9.7M | Buy |
|
|||||
|
2024
Q1 | $4.73M | Sell |
|
|||||
|
2023
Q4 | $11.3M | Buy |
|
|||||
|
2023
Q3 | $10.6M | Sell |
|
|||||
|
2023
Q2 | $12.1M | Sell |
|
|||||
|
2023
Q1 | $14.7M | Buy |
|
|||||
|
2022
Q4 | $15.8M | Sell |
|
|||||
|
2022
Q3 | $22.6M | Sell |
|
|||||
|
2022
Q2 | $24.7M | Buy |
|
|||||
|
2022
Q1 | $7.78M | Buy |
|
|||||
|
2021
Q4 | $4.55M | Buy |
|
|||||
|
2021
Q3 | $2.05M | Sell |
|
|||||
|
2021
Q2 | $11.4M | Sell |
|
|||||
|
2021
Q1 | $16.3M | Sell |
|
|||||
|
2020
Q4 | $19.7M | Buy |
|
|||||
|
2020
Q3 | $7.79M | Sell |
|
|||||
|
2020
Q2 | $13.6M | Buy |
|
|||||
|
2020
Q1 | $1.16M | Sell |
|
|||||
|
2019
Q4 | $1.24M | Buy |
|
|||||
|
2019
Q3 | $850K | Buy |
|
|||||
|
2019
Q2 | $737K | Buy |
|
|||||
|
2019
Q1 | $551K | Buy |
|
|||||
|
2018
Q4 | $432K | Buy |
|
|||||
|
2018
Q3 | $254K | Sell |
|
|||||
|
2018
Q2 | $353K | Sell |
|
|||||
|
2018
Q1 | $1.99M | Buy |
|